Companies like Lovable, Base44, Replit, and Netlify use AI to let anyone build a web app in seconds—and in thousands of cases ...
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...
New York’s Commercial Division Rule 25-a, effective November 2025, promotes the use of the Virtual Evidence Courtroom (VEC), ...
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...
AI-powered presentation tools are transforming how slides, visuals, and narratives are created, with platforms like Gamma, AI PPT 2026, Beautiful.ai, Canva, and SlideGMM offering varied strengths from ...
Obesity, hypertension, hyperlipidemia, type 2 diabetes, obstructive sleep apnea, and hypothyroidism were independent MRFs for MASLD overall, but the ranking of these MRFs by odds ratios could vary by ...
Every IT professional has sat through a vendor presentation where an incremental software update is pitched as a civilization-altering event. In late March 2026, the artificial intelligence industry ...
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
(MENAFN- GlobeNewsWire - Nasdaq) ROCKVILLE, Md. and SUZHOU, China, April 21, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, ...
TEL AVIV, Israel, April 21, 2026 (GLOBE NEWSWIRE)-- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a ...
Amid growing opposition to data centers in Harford County, the County Council heard a presentation of a different tone on Tuesday. Although no data centers have yet been proposed in the county, ...
RESEARCH TRIANGLE PARK, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...